Infect Dis Ther. 2026 Mar 30. doi: 10.1007/s40121-026-01313-8. Online ahead of print.
ABSTRACT
INTRODUCTION: Respiratory syncytial virus (RSV) poses a significant health risk to older adults, particularly those with chronic comorbidities, in the Gulf Cooperation Council (GCC) countries. Despite its high burden, RSV remains underrecognized among older adults in this region. This manuscript aims to highlight the burden of RSV among older adults in GCC countries and provide expert consensus recommendations for the implementation of targeted prevention measures, including vaccination strategies.
METHODS: A multidisciplinary panel of experts from GCC countries reviewed international, regional, and country-level data on RSV. The panel formulated recommendations on the basis of a comprehensive literature review and expert consensus, focusing on the integration of RSV vaccination into routine immunization programs for older adults.
RESULTS: Older adults, especially those with chronic conditions including but not limited to cardiovascular disease, chronic kidney disease, chronic lung disease, and diabetes, are at an increased risk for severe RSV-related outcomes. Effective vaccines present an opportunity to significantly reduce the incidence and severity of RSV in this vulnerable population. Key recommendations for safeguarding older adults in GCC countries include implementing clear immunization schedules for adults at a country-level that include targeted RSV vaccination, especially among high-risk groups. Providing continuous education for healthcare professionals, increasing vaccine availability, equity, and affordability, conducting public awareness campaigns, and strengthening local surveillance systems also play a crucial role in addressing vaccine-preventable diseases such as RSV.
CONCLUSIONS: Integrating RSV vaccination into routine immunization schedules, alongside other key vaccines, is essential for achieving comprehensive and optimal protection for older adults in GCC countries.
PMID:41910687 | DOI:10.1007/s40121-026-01313-8